In this blog we’ll explore these platforms’ tools for view settings adjustment for fluorescent images and the integrated Figure Maker tool. Together, these features equip researchers to accurately observe and convey the complexity of their samples and the details of their analysis.
26 – 28 June 2025 | Visit us at booth #19 for a live demonstration of the latest developments across our HALO clinical and life science products on June 26-28 or prebook a meeting at our booth.
11 June 2025 | Learn the basics of multiplex fluorescence image analysis!
Getting Started with Multiplex Fluorescence Image Analysis in HALO® Read More »
22 May 2025 | Learn the basics of in situ hybridization image analysis!
Getting Started with In Situ Hybridization in HALO® Read More »
27 – 30 April 2025 | Stop by our booth #2524 to see live demonstrations of HALO®, HALO AI, and HALO Link or prebook a meeting at our booth.
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.
Indica Labs’ Boston HALO® User Group Meeting Read More »
We’re excited to announce the launch of the newly updated Vacuole, Object Colocalization BF, and Object Colocalization FL modules supporting interactive markups.
3 April 2025 | Join us for an introductory webinar on brightfield image analysis in HALO®, designed for beginners. We’ll walk through key digital pathology workflows, including singleplex, multiplex, and H&E image analysis. You’ll learn essential object detection methods for identifying cells, tissue structures, and regions of interest.
Getting Started with Brightfield Image Analysis in HALO® Read More »
At Indica Labs, our HALO platforms are optimized for ease-of-use as well as powerful, accurate analysis, and include multiple features to help users get the most from their data.
Interactive Markup Images: Providing a Dynamic Look at HALO® Analysis Results Read More »
Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality
